Regina Brinster

Papers

Total Citations

H-Index

About

Regina Brinster is a leading figure in urologic oncology, whose work has significantly advanced the surgical management of kidney cancer. Her primary research focuses on comparative effectiveness in nephron-sparing surgery, with a particular emphasis on robotic-assisted techniques. Brinster’s landmark study, the "Robocop" analysis, is a cornerstone of her impact. This propensity score-matched investigation of 249 patients provided rigorous, real-world evidence comparing robotic-assisted partial nephrectomy (RAPN) to conventional open surgery. By introducing the Comprehensive Complication Index (CCI) as a more sensitive endpoint for postoperative morbidity, she offered a novel framework for evaluating surgical quality. Her findings have helped clarify the relative benefits of minimally invasive approaches, directly informing clinical decision-making for surgeons and patients. With her most cited work accumulating 26 citations, Brinster’s contributions are shaping the evidence base for modern urologic practice. Her dedication to methodologically robust, patient-centered outcomes research continues to influence the evolution of surgical oncology, making her a respected voice in the ongoing dialogue between technological innovation and clinical efficacy.